Apixaban and Nitrolingual drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apixaban (apixaban) and Nitrolingual (nitroglycerin). Common drug interactions include palpitations among females and general physical health deterioration among males.

The phase IV clinical study analyzes what interactions people have when they take Apixaban and Nitrolingual. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Nitrolingual?

Nitrolingual has active ingredients of nitroglycerin. eHealthMe is studying from 2,777 Nitrolingual users. Check the latest studies of Nitrolingual.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

50 people who take Apixaban and Nitrolingual together, and have interactions are studied.

Apixaban and Nitrolingual drug interactions.

What are the common drug interactions of Apixaban and Nitrolingual, by gender? *:

female:

Palpitations (feelings or sensations that your heart is pounding or racing)
Somnolence (a state of near-sleep, a strong desire for sleep)
Thalamus haemorrhage (bleeding in thalamus)
Anxiety
Bladder transitional cell carcinoma recurrent (types of bladder cancer-recurrent)
Bladder transitional cell carcinoma stage ii (types of bladder cancer stage ii)
Decreased activity
Emotional distress
Exercise tolerance decreased
Fear of disease

male:

General physical health deterioration (weak health status)
Electrocardiogram qt prolonged
Staphylococcal infection (an infection with staphylococcus bacteria)
Bowen's disease (early stage of skin cancer)
Dizziness
Ear neoplasm malignant (ear cancerous tumour)
Hypoaesthesia (reduced sense of touch or sensation)
Influenza
Injection site swelling
Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Apixaban and Nitrolingual, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

General physical health deterioration (weak health status)
Electrocardiogram qt prolonged
Dyspnoea exertional (breathlessness or shortness of breath)
Faeces discoloured
Fall
Hypertensive crisis
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 9 people, 18.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 16.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 8.00%
Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 3 people, 6.00%
Splenomegaly (enlargement of spleen): 3 people, 6.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 6.00%
Pain: 3 people, 6.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 3 people, 6.00%
High Blood Pressure: 3 people, 6.00%
Chest Pain: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and Nitrolingual?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously